![](/img/cover-not-exists.png)
A Quality-Adjusted Time without Symptoms of Disease And Toxicity (Q-TWIST) Analysis Comparing Nivolumab and Therapy Of Investigator’s Choice (IC) in Patients with Recurrent or Metastatic (R/M) Platinum-Refractory Squamous Cell Carcinoma of the Head and Neck (SCCHN) (Checkmate 141)
Simpson, S, Cocks, K, Contente, M, DeRosa, M, Taylor, F, Shaw, JWVolume:
20
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2017.08.292
Date:
October, 2017
File:
PDF, 58 KB
english, 2017